UBC’s approach to clinical research and safety puts the focus on real world data.
Ensure conclusive study results to support drug approval and market access.
Epidemiologic approach to the collection and analysis of data for understanding diseases, establishing patient cohorts, and meeting post-marketing regulatory requirements.
Exceptional intake processing, analysis and reporting on product patient safety.
Understanding and evaluating product risk by managing risk before, during, and after launch.
Meet FDA requirements to manage a known or potential serious risk.
Product safety, effectiveness, & regulatory consulting to the pharmaceutical, biotech, and device industries.
Specialized needs require a customized approach to ensure all product, patient, and market requirements are met. UBC’s comprehensive global services help pharmaceutical and biotech clients prove their products’ effectiveness, safety and value.